Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines.
Ryoko TakeiTomoaki InoueNoriyuki SonodaMotoyuki KohjimaMisato OkamotoRyuichi SakamotoToyoshi InoguchiYoshihiro OgawaPublished in: PloS one (2019)
Bilirubin may protect against insulin resistance by ameliorating visceral obesity and adipose tissue inflammation.